Goto W, Kashiwagi S, Takada K, Asano Y, et al. Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer. Anticancer Res 2022;42:939-946.
PMID: 35093893